Zdrowie i gospodarka · 26/06/2026
FDA Classifies External Lower Extremity Nerve Stimulator for Restless Legs Syndrome into Class II
The FDA has classified the external lower extremity nerve stimulator for treating Restless Legs Syndrome into Class II, a move expected to enhance patient access to innovative devices while ensuring safety and effectiveness.
Source: Federal Register — Health and Human ServicesOpen original release →